home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Genetic News | search  

Stem Cell Stability

  May, 3 2005 7:13
your information resource in human molecular genetics
A potential barrier to the therapeutic use of human embryonic stem cells appears to be less of a concern than previously thought, according to a study published in the June 2005 issue of Nature Genetics. Peter Rugg-Gunn and colleagues report that the status of so-called 'imprinted' genes, in which only one copy of the gene is expressed, is generally normal in a sampling of such genes in a series of human stem cell lines grown in culture dishes.

Previous work had shown that imprinted genes in embryonic stem cells generated from mouse embryos had altered expression patterns. As such aberrant gene expression might affect the viability or proper functioning of the cells when introduced into individuals as a replacement for diseased cells, it was feared that this represented a major obstacle to their therapeutic use.

Rugg-Gunn and colleagues examined six genes and three other regions of the human genome that are involved in imprinting -- all but one of which had the normal pattern of expression in the human stem cell lines. Although they note that it is possible that the expression of other genes might be altered in human embryonic stem cells, the current work suggests a greater degree of stability than anticipated.

Author Contact:

Peter Rugg-Gunn (University of Cambridge, UK)
E-mail: pjr36@cam.ac.uk

Online version of publication available here.

(C) Nature Genetics press release.

Message posted by: Trevor M. D'Souza

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2023 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.